Skip to main content
. 2021 Jan 17;12(8):1400–1407. doi: 10.1111/jdi.13481

Figure 2.

Figure 2

Onset times of sodium–glucose cotransporter 2 inhibitors (SGLT2is) and glucose‐lowering medications regimens. D, dipeptidyl peptidase‐4 inhibitors; G, glucagon‐like peptide 1 receptor agonists; M, metformin; S, sulfonylurea; T, thiazolidinedione.